Accretion Nutraveda Limited (BOM:544694)

Market Cap	1.89B
Revenue (ttm)	337.16M +1,022.8%
Net Income	50.68M +1,706.2%
EPS	9.35 +1,099.6%
Shares Out	7.24M
PE Ratio	27.97
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,000
Open	255.00
Previous Close	n/a
Day's Range	250.75 - 261.50
52-Week Range	129.00 - 300.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 8, 2026

About Accretion Nutraveda

Accretion Nutraveda Limited manufactures and sells ayurvedic and nutraceutical products in India and Internationally. The company focuses on ayurvedic and nutraceutical products, including tablets, capsules, oral liquids, oral powders, external preparations, and oils. Its product portfolio includes tablets, such as film-coated and chewable varieties, for applications in liver care, gynecological care, bone and joint health, and respiratory support; capsules comprising hard gelatin and HPMC capsules, targeting areas like liver detoxification, wo...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 2021
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544694

Financial Performance

In fiscal year 2026, Accretion Nutraveda's revenue was 337.16 million, an increase of 110.07% compared to the previous year's 160.49 million. Earnings were 50.68 million, an increase of 93.98%.